Cart
sales@molnova.com
AS 602801
CAS No. 848344-36-5
AS 602801( AS602801 | PGL-5001 | PGL 5001 | Bentamapimod )
Catalog No. M17611 CAS No. 848344-36-5
AS 602801(Bentamapimod) is a novel, orally active inhibitor of JNK.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 96 | In Stock |
|
| 25MG | 157 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 343 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1125 | In Stock |
|
| 1G | 2037 | In Stock |
|
Biological Information
-
Product NameAS 602801
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS 602801(Bentamapimod) is a novel, orally active inhibitor of JNK.
-
DescriptionBentamapimod, also known as AS602801 and PGL5001, is a JNK Inhibitor. AS602801 induces regression of endometriotic lesions in animal models. AS602801 interrupts immune pathways. Bentamapimod induced regression of endometriotic lesions in endometriosis rodent animal models without suppressing ER action. Endometriosis is an estrogen (ER)-dependent gynecological disease caused by the growth of endometrial tissue at extrauterine sites.
-
In Vitro——
-
In Vivo——
-
SynonymsAS602801 | PGL-5001 | PGL 5001 | Bentamapimod
-
PathwayOthers
-
TargetOther Targets
-
RecptorJNK1| JNK2| JNK3
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number848344-36-5
-
Formula Weight457.55
-
Molecular FormulaC25H23N5O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 14.29 mg/mL. 31.23 mM;
-
SMILESN#CC(c1nc2ccccc2s1)c1nc(OCc2ccc(CN3CCOCC3)cc2)ncc1
-
Chemical Name2-(1,3-benzothiazol-2-yl)-2-[2-({4-[(morpholin-4-yl)methyl]phenyl}methoxy)pyrimidin-4-yl]acetonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cy5.5
Cy5.5 is a near-infrared fluorescent dye for labeling biomolecules such as peptides, proteins and oligonucleotides (Ex=673 nm, Em=707 nm).
-
E-3030
E-3030 free acid is a potent dual activator of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma, exhibiting significant antidiabetic and lipid-modulating effects. E-3030 decreases blood glucose, triglyceride, non-esterified fatty acids, and insulin levels, while increasing blood adiponectin levels. E-3030 improves glucose tolerance and shows remarkable triglyceride- and non-high-density lipoprotein cholesterol-lowering effects in animal models.
-
BB-78485
BB-78485 is a potent small molecule inhibitor of LpxC metalloenzymes with antibacterial activity. The IC50 value of BB-78485 against LpxC is 160 nM. BB-78485 can be used for the study of Gram-negative bacterial infections.
